Lead Product(s) : HA Matrix
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Study to Evaluate the Anti-aging Efficacy of Dermial®
Details : HA Matrix is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Skin Aging.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
April 14, 2023
Lead Product(s) : HA Matrix
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioiberica Joins a European Project to Develop Treatments for Complex Wounds
Details : Aim is to develop innovative multifunctional biomaterials to heal wounds using affordable EU-based manufacturing technologies.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 18, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate
Therapeutic Area : Dermatology
Study Phase : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
New Study Reveals Bioiberica's Dermial® Delivers Superior Benefits for Skin Health
Details : New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.
Product Name : Dermial
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 25, 2022
Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate
Therapeutic Area : Dermatology
Highest Development Status : Preclinical
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Native Type Ii Collagen
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort
Details : Native Type Ii Collagen is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Arthralgia.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
March 16, 2022
Lead Product(s) : Native Type Ii Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undenatured Type II Collagen
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : ByHealth
Deal Size : Undisclosed
Deal Type : Partnership
New Partnership With ByHealth in China
Details : By partnering with Bioiberica, ByHealth aims to capitalise on the untapped potential of new product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient produ...
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Undisclosed
March 11, 2022
Lead Product(s) : Undenatured Type II Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : ByHealth
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : Chondroitin Sulfate Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioiberica Rebrands Its Range of Nutraceutical Ingredients for Healthcare
Details : Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.
Product Name : CSbioactive
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 05, 2021
Lead Product(s) : Chondroitin Sulfate Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hyaluronic Acid,Type II Collagen
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Apsen
Deal Size : Undisclosed
Deal Type : Partnership
Bioiberica and Apsen Reinforce Partnership with New Holistic Mobility Product–Motilex HA
Details : Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint...
Product Name : Motilex HA
Product Type : Miscellaneous
Upfront Cash : Undisclosed
April 26, 2021
Lead Product(s) : Hyaluronic Acid,Type II Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Apsen
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : Undenatured Type II Collagen,Chondroitin Sulfate Sodium,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The study, conducted in a rabbit model of osteoarthritis, set out to evaluate the effects of b-2Cool native type II collagen in combination with CS b-Bioactive chondroitin sulphate, glucosamine hydrochloride and Mobilee® which is a rooster comb extract ...
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
September 07, 2020
Lead Product(s) : Undenatured Type II Collagen,Chondroitin Sulfate Sodium,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
July 15, 2020
Lead Product(s) : Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hyaluronic Acid,Type II Collagen,Undisclosed
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Recipient : Nestle Health Sciences SA
Deal Size : Undisclosed
Deal Type : Partnership
Details : Nestlé Health Science is incorporating Bioiberica’s patented ingredient, Mobilee®, into its MERITENE® Mobilis® joint-health drink mix.
Product Name : Meritene Mobilis
Product Type : Miscellaneous
Upfront Cash : Undisclosed
June 16, 2020
Lead Product(s) : Hyaluronic Acid,Type II Collagen,Undisclosed
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Recipient : Nestle Health Sciences SA
Deal Size : Undisclosed
Deal Type : Partnership
KEY PRODUCTS
Reset All
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
